Viewing Study NCT02926768


Ignite Creation Date: 2025-12-24 @ 5:53 PM
Ignite Modification Date: 2026-02-26 @ 12:04 PM
Study NCT ID: NCT02926768
Status: COMPLETED
Last Update Posted: 2022-07-26
First Post: 2016-09-29
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors
Sponsor: Checkpoint Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module